Dr. Federico V Pallardó studied Medicine in the Faculty of Medicine at the University of Valencia where he obtained his degree with first class honors in 1985 and obtained his doctorate with cum laude honors. Postgraduate fellow at Oxford University (UK) and postdoctoral fellow at the Harvard Medical School (USA), where he was awarded a prestigious NATO fellowship. He is Full Professor at the University and was dean of the Faculty of Medicine and Odontology in the University of Valencia. He was also a visiting professor at the Chicago Medical School and later the Director of the INCLIVA Central Research Unit where he coordinated the basic research laboratories for more than ten years. He is scientific director of the Centre of Networked Biomedical Research in Rare Diseases (CIBERER-BIOBANK). He has over 190 scientific publications, regularly contributes to prestigious international journals, and has managed 21 doctoral theses. His h-index is currently 52, and he has more than 9,000 citations. He has been the secretary of the Society for Free Radical Research Europe (SFRR Europe) and has received several national and international awards
Identify oxidative stress biomarkers in rare neuromuscular diseases.Identification of epigenetic biomarkers in rare diseases. Specialized rare diseases training course for healthcare staff. Identify epigenetic biomarkers associated with inflammatory processes, septic shock, and severe sepsis. Identification of post-translational histone.
Get to know us better
The people who make it all possible
Federico Pallardo Calatayud
Rubén Artero Allepuz
Jorge Espinosa Espinosa
María Sabater Arcis
Jose Luis Garcia Gimenez
Marta Seco Cervera
Manuel Perez Alonso
Jose Santiago Ibañez Cabellos
Mª Beatriz Llamusi Troisi
Estefania Cerro Herreros
Pilar Gonzalez Cabo
Carlos Romá Mateo
Our scientific contributions
Friedreich Ataxia: current state-of-the-art, and future prospects for mitochondrial-focused therapies.
Pallardó FV, Pagano G, Rodríguez LR, Gonzalez-Cabo P, Lyakhovich A and Trifuoggi M
Translational Research, 2021 Mar,  DOI:  10.1016/j.trsl.2020.08.009,  Vol. 229,  pag. 135-141
Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
Ibáñez-Cabellos JS, Pérez-Machado G, Seco-Cervera M, Berenguer-Pascual E, García-Giménez JL and Pallardó FV
Redox Biology, 2018 Apr,  DOI:  10.1016/j.redox.2017.10.004,  Vol. 14,  pag. 398-408
Histone h3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure.
García-Giménez JL, Òlaso G, Hake SB, Bönisch C, Wiedemann SM, Markovic J, Dasí F, Gimeno A, Pérez-Quilis C, Palacios O, Capdevila M, Viña J and Pallardó FV
ANTIOXIDANTS & REDOX SIGNALING, 2013 Oct,  DOI:  10.1089/ars.2012.5021,  Vol. 19,  pag. 1305-1320
Role of glutathione in the regulation of epigenetic mechanisms in disease
J. GARCIA-GIMENEZ, C. ROMA-MATEO, G. PEREZ-MACHADO, L. PEIRO-CHOVA and F. PALLARDO
FREE RADICAL BIOLOGY AND MEDICINE, 2017 Nov,  DOI:  10.1016/j.freeradbiomed.2017.07.008,  Vol. 112,  pag. 36-48
Oxidative stress and antioxidant response in fibroblasts from Werner and atypical Werner syndromes.
Seco-Cervera M, Spis M, García-Giménez JL, Ibañez-Cabellos JS, Velázquez-Ledesma A, Esmorís I, Bañuls S, Pérez-Machado G and Pallardó FV
Aging-US, 2014 Mar,  DOI:  10.18632/aging.100649,  Vol. 6,  pag. 231-245